EO decisions and CED recommendations

Information on drug funding decisions based on Executive Officer (EO) decisions and Committee to Evaluate Drugs (CED) recommendations. This information is intended for medical professionals and drug manufacturers.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 19:19 (UTC)
Created April 17, 2026, 19:19 (UTC)
contact_person {"en": "Health", "fr": "Health"}
criticality_level []
data_dictionary ["economy"]
geographic_scope []
open_canada_collection federated
open_canada_date_published 2023-10-20 00:00:00
open_canada_keywords {"en": ["Données Ontario", "Committee to Evaluate Drugs", "CED recommendations", "drug funding decisions", "Ontario drug review"], "fr-t-en": ["Ontario data", "Comité d'évaluation des médicaments", "Recommandations du CED", "décisions relatives au financement des médicaments", "Programme d'évaluation des médicaments en Ontario"]}
open_canada_subject ["government_and_politics"]
sensitivity_level unrestricted
title_fr Recommandations du DG et du CEM
update_frequency unknown